KIAA0930 expression was upregulated in pancreatic cancer (PaCa; GSE15471, GSE16515, and GSE32676), colorectal cancer (CRC; GSE8671, GSE9348, and GSE20916), gastric cancer (GC; GSE13911, GSE19826, and GSE29272), oral squamous cell carcinoma (OSCC; GSE25099) and tongue cancer (TC; GSE6791 and GSE9844) (Figure 1A–1D), which have a high risk for CC [16, 17]. Here, KIAA0930 is linked to colorectal carcinoma.